Literature DB >> 11304476

Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice.

K Aalto-Setälä1, K Laitinen, L Erkkilä, M Leinonen, M Jauhiainen, C Ehnholm, M Tamminen, M Puolakkainen, I Penttilä, P Saikku.   

Abstract

In epidemiological studies, an association between cardiovascular disease and Chlamydia pneumoniae (C pneumoniae) infection has been observed. Although C pneumoniae has been shown to be present in atherosclerotic lesions, a causal relationship between C pneumoniae infection and atherosclerosis has not been demonstrated. To study this question, we used 2 strains of apolipoprotein (apo) E-deficient mice. Eight-week-old mice on an FVB background that were maintained on either a low- or a high-fat diet were infected 3 times at 1-week intervals with C pneumoniae, and atherosclerotic lesions were measured in the aortic root at 10 weeks after the primary infection. In each of the diet groups, no difference in the extent of atherosclerosis could be observed between the C pneumoniae-infected and control animals. In further studies, 2 strains of apoE-deficient mice (FVB or C57BL/6J background) were infected 4 times at 3- to 4-week intervals, and the extent of atherosclerosis was analyzed 18 weeks later. The mice were kept on either a low- or a high-fat diet. The high-fat diet increased atherosclerosis, and a difference in atherosclerosis susceptibility between the mouse strains was observed. However, C pneumoniae infection did not influence lesion size in either mouse strain. On the other hand, C pneumoniae could not be demonstrated by polymerase chain reaction in any of the atherosclerotic lesions of the infected animals studied. A small decrease in serum cholesterol and triglyceride levels 3 days after the primary infection occurred, but after that no differences in serum lipid levels compared with those in noninfected animals were evident. In the myocardium of C pneumoniae-infected mice, no inflammatory signs could be observed. We conclude that under the experimental conditions used, C pneumoniae infection does not accelerate atherogenic changes in the aortic root of apoE-deficient mice.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11304476     DOI: 10.1161/01.atv.21.4.578

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  13 in total

1.  Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).

Authors:  Karuna P Karunakaran; James F Blanchard; Ausra Raudonikiene; Caixia Shen; Andrew D Murdin; Robert C Brunham
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

Review 2.  Toll-like receptors and atherosclerosis: key contributors in disease and health?

Authors:  Adam E Mullick; Peter S Tobias; Linda K Curtiss
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

3.  Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques.

Authors:  G Arno; J C Kaski; D A Smith; J P Akiyu; S E Hughes; C Baboonian
Journal:  Heart       Date:  2005-04       Impact factor: 5.994

4.  Chlamydia pneumoniae and Cardiovascular Disease.

Authors:  Maria Kolia; Ignatius William Fong
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

5.  Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.

Authors:  Liisa Törmäkangas; Hannu Alakärppä; Denise Bem David; Maija Leinonen; Pekka Saikku
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model.

Authors:  Victoria L M Herrera; Li Shen; Lyle V Lopez; Tamara Didishvili; You-Xun Zhang; Nelson Ruiz-Opazo
Journal:  Mol Med       Date:  2003 May-Aug       Impact factor: 6.354

7.  Chlamydia pneumoniae Infection and Inflammatory Diseases.

Authors:  Rebecca A Porritt; Timothy R Crother
Journal:  For Immunopathol Dis Therap       Date:  2016

8.  Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice.

Authors:  Erwin Blessing; Lee Ann Campbell; Michael E Rosenfeld; Cho-chou Kuo
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

Review 9.  Vaccination and atherosclerosis.

Authors:  Xinghua Zhou; Göran K Hansson
Journal:  Curr Atheroscler Rep       Date:  2004-03       Impact factor: 5.113

10.  TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis.

Authors:  Yoshikazu Naiki; Rosalinda Sorrentino; Michelle H Wong; Kathrin S Michelsen; Kenichi Shimada; Shuang Chen; Atilla Yilmaz; Anatoly Slepenkin; Nicolas W J Schröder; Timothy R Crother; Yonca Bulut; Terence M Doherty; Michelle Bradley; Zory Shaposhnik; Ellena M Peterson; Peter Tontonoz; Prediman K Shah; Moshe Arditi
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.